Definitive Contract 75N91022C00020
Award Date 9/15/22
Potential Completion Date 9/14/24
Potential Value $2M
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Peabody, MA 01960, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
13
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase II Action
Primary Consortia Member
Not listed Similar Awards
- This is a $400,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH). The contract was awarded to Veloxai LLC, a self-certified small disadvantaged business, to develop an automatic treatment planning system for high-dose rate brachytherapy for cervical cancer in low-resource settings. The contract was set aside for total small businesses and has a completion date of September 14,...
- This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Veloxai LLC, a small disadvantaged business. The contract is for the development of automatic treatment planning software for cervical cancer high-dose rate brachytherapy in low-resource settings, pursuant to SBIR Topic 431. The contract has a ceiling value of $2,000,000.00 and is a definitive, firm-fixed-price contract with a final completion date...
- This is a $399,062 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Avoneaux Medical Institute, LLC for the development of spatial micro-purification technology. The contract was set aside for small businesses and is part of the NCI's broader SBIR program, which funds research and development in support of the NIH and CDC's mission needs. The original solicitation sought proposals on a range of cancer-related topics, including alternatives to cell...
- This SBIR Phase I contract was awarded by the National Institutes of Health National Cancer Institute to Outcomes4Me Inc. for $452,514. The contract is for the period of September 16, 2020 through September 15, 2022 and involves developing mobile health technology to utilize cancer survivorship navigation for patient benefit. The solicitation sought proposals to conduct research and development in support of NIH and CDC agency missions, including topics related to cancer immunotherapy...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), an institute of the National Institutes of Health (NIH), to Lucidact Inc., a minority-owned and disadvantaged small business located in Los Angeles, CA. The $454,524 fixed-price contract is for the development of a digital tool to integrate cancer prevention within primary care, as part of the broader SBIR program objectives to stimulate technological innovation and strengthen the...
- This is a $389,973 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Ai Biosciences, Inc., a small disadvantaged biotechnology company. The contract is for the development of a "Rapid Isothermal Amplification Chip for HPV Detection and Genotyping in Low-Resource Settings." This aligns with NCI's mission to support cancer research and diagnostic technologies,...
- This $399,951 firm-fixed-price definitive contract was awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to the small business Care Progress LLC. The contract supports the development of "BIOMARKERAWARE: A NOVEL SYSTEM TO IMPROVE PRECISION ONCOLOGY" under the NCI's Small Business Innovation Research (SBIR) program, which is a set-aside for small businesses. Care Progress LLC, a for-profit limited liability company, has previously...
- This is a $382,034 Small Business Innovation Research (SBIR) Phase I contract awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Phoenix Biosystem, Inc., a self-certified small disadvantaged business. The contract is for the development of HPV point-of-care molecular diagnostics for low- and middle-income countries. The original pre-solicitation announced that NIH and CDC were seeking SBIR proposals to advance their infectious...
- This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
- This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...